Indian Drug Manufacturers' Association (IDMA) & APTAR PHARMA invite you..
WEBINAR on:
“INTRANASAL IMMUNIZATION: PROMISES and CHALLENGES"
DATE:
September 2, 2021, Thursday
TIME:
4:30 pm to 6:00 pm (India Standard Time)
copy the link and past it in the web browser
The International Speakers:
Dr. Julie Suman
President Next Breath
Aptar Pharma company
Nektaria Karavas
Business Development Director
Aptar Pharma Company
The Abstract:
EXPLORING INTRANASAL VACCINATION FOR NEEDLE-FREE IMMUNIZATION
Today, there are three marketed nasal vaccines available for human use but many more are in development for both human and veterinary use. Nasal vaccination provides an alternative to the more conventional Injectable drug delivery system. Mucosal immunity can develop via interaction with immune modulators present in the nasal cavity, where the nasal associated lymphoid tissue (NALT) region plays a dominant role.
In this webinar, we will provide an overview of intranasal vaccine formulations for liquid and powder administration. We will then discuss the pros and cons of nasal vaccines, assess intranasal device platforms, logistical considerations that need to be taken into account, as well as present our thoughts on the opportunities that intranasal vaccination can offer.
The webinar shall be of interest to the following professionals:
NOTE:
Kindly note that there are no registration fees for this webinar, but prior registration is compulsory.
For more information / assistance, please contact:
Ms. Prachi Singhai
APTAR
Manager‑Marketing & Communication, India & SE Asia
M: +91.98920.26098
T: +91.22.6195.1900
E: prachi.singhai@aptar.com
W: www.aptar.com
APTAR PHARMA INDIA PRIVATE LIMITED, part of Aptargroup, Inc., Crystal Lake, Illinois, USA, and having registered office at R - 854 , TTC Industrial Estate Thane Belapur Road, MIDC RABALE, Navi Mumbai, 400701 Mumbai, India. Tel. + 91 22 61951900
